The Potential and Challenges of Expanded Germline Testing in Clinical Oncology

The concept of precision cancer medicine, including systematic molecular characterization of tumor samples for use in care decisions, is undergoing prospective evaluation in populations of patients with advanced cancer. Such studies have already enabled numerous significant discoveries in translational cancer research. Here, Allen details Mandelker and colleagues' study on the effectiveness of germline molecular assay.